Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completed

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

NCT06009484
completed

A National Study of Clinical Results After Emergency Operation for Perforated Diverticulitis

NCT03332550
withdrawn

Anesthesia and Immunological and Oxidative Stress in Relation to Abdominal Cancer Surgery

NCT03974984
completednot_applicable

Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis

NCT01986686

Clinical Trials (4)

Showing 4 of 4 trials
NCT06009484

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Completed
NCT03332550

A National Study of Clinical Results After Emergency Operation for Perforated Diverticulitis

Completed
NCT03974984

Anesthesia and Immunological and Oxidative Stress in Relation to Abdominal Cancer Surgery

Withdrawn
NCT01986686Not Applicable

Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4